Cart
sales@molnova.com
WHI-P131
CAS No. 202475-60-3
WHI-P131( Janex 1 )
Catalog No. M13153 CAS No. 202475-60-3
Janex-1 is a cell-permeable, reversible, potent, ATP-competitive, and specific inhibitor of JAK3.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 45 | In Stock |
|
| 5MG | 76 | In Stock |
|
| 10MG | 138 | In Stock |
|
| 25MG | 235 | In Stock |
|
| 50MG | 421 | In Stock |
|
| 100MG | 617 | In Stock |
|
| 500MG | 1305 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameWHI-P131
-
NoteResearch use only, not for human use.
-
Brief DescriptionJanex-1 is a cell-permeable, reversible, potent, ATP-competitive, and specific inhibitor of JAK3.
-
DescriptionJanex-1 is a cell-permeable, reversible, potent, ATP-competitive, and specific inhibitor of JAK3 (IC50 = 78μM); has no effect on JAK1, JAK2, or Zap/Syk or SRC tyrosine kinases.
-
In Vitro——
-
In Vivo——
-
SynonymsJanex 1
-
PathwayAngiogenesis
-
TargetJAK
-
RecptorJAK3| JAK3
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number202475-60-3
-
Formula Weight297.31
-
Molecular FormulaC16H15N3O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESOC1=CC=C(NC2=C3C=C(OC)C(OC)=CC3=NC=N2)C=C1
-
Chemical Name4-[(6,7-dimethoxy-4-quinazolinyl)amino]-phenol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sudbeck EA, et al. Clin Y Res. 1999 Jun;5(6): 1569-82.
molnova catalog
related products
-
Delgocitinib
Delgocitinib (JTE-052, LEO 124249) is a potent, selective, orally active, pan-JAK inhibitor with IC50 of 2.8, 2.6, 13 and 58 nM for JAK1,2,3 and Tyk2, respectively. ?
-
NVP-BSK805
A potent, selective and ATP-competitive inhibitor of JAK2(V617F) and wt JAK2 (IC50=0.5 nM).
-
Nimucitinib
Nimucitinib is a Janus kinase (JAK) inhibitor that can be used to treat dry eye and promote tear production.
